BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,440.00
+140.00 (1.69%)
At close: Aug 11, 2026

BIO-FD&C Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
6,1986,6664,5015,5854,3352,908
Depreciation & Amortization
1,3691,3211,2131,0871,049626.04
Loss (Gain) From Sale of Assets
-18.18-18.180.19-0.43--8.88
Loss (Gain) From Sale of Investments
-531.31-531.311,106-1,1703.63-
Stock-Based Compensation
--13.5654.4837.3940.99
Provision & Write-off of Bad Debts
38.6133.13-64.1840.29-17.8776.61
Other Operating Activities
344.77740.57-367.74383.26254.35223.55
Change in Accounts Receivable
-175.25-872.01105.01-319.061,195-1,275
Change in Inventory
-502.17-54.19-358.96-444.74-391.12-436.39
Change in Accounts Payable
119.03-15.975.767.42-1,1501,204
Change in Other Net Operating Assets
47.829.37-186.39763.64-542.76328.35
Operating Cash Flow
6,8907,2796,0376,0475,5733,687
Operating Cash Flow Growth
14.66%20.56%-0.15%8.50%51.16%74.12%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,014-974.37-1,259-1,989-152.44-7,017
Sale of Property, Plant & Equipment
18.1818.18-25.54--
Sale (Purchase) of Intangibles
-76.49-74.2-37.83-339.87-72.59.15
Investment in Securities
-1,904-2,177-9,140-919.57-29,4683,632
Other Investing Activities
156.98156.98-7.46-2.2332.631,019
Investing Cash Flow
-2,761-2,982-10,305-3,306-30,605-2,357

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---3001,200600
Long-Term Debt Issued
-----300
Total Debt Issued
---3001,200900
Short-Term Debt Repaid
--1,100--2,200--
Long-Term Debt Repaid
--95.33-54.23-325.38-1,644-317.89
Total Debt Repaid
-1,208-1,195-54.23-2,525-1,644-317.89
Net Debt Issued (Repaid)
-1,208-1,195-54.23-2,225-444.29582.11
Issuance of Common Stock
----34,916-
Repurchase of Common Stock
-----2,994-
Other Financing Activities
------0
Financing Cash Flow
-1,208-1,195-54.23-2,22531,478582.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
77.43-2.4999.35-43.41-14.1997.47
Miscellaneous Cash Flow Adjustments
-0-0---0-0
Net Cash Flow
2,9993,099-4,223472.46,4312,009

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
5,8776,3044,7794,0575,421-3,330
Free Cash Flow Growth
5.30%31.93%17.77%-25.15%--
Free Cash Flow Margin
31.17%32.87%29.74%26.02%34.19%-27.82%
Free Cash Flow Per Share
688.56738.65560.57475.82615.19-450.12
Levered Free Cash Flow
3,9634,2002,6431,8923,128-4,333
Unlevered Free Cash Flow
3,9804,2242,6831,9723,196-4,294

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
31.8341.0763.49132.23110.3461.07
Cash Income Tax Paid
1,249960.1974.31,366927.08356.02
Change in Working Capital
-510.57-932.73-364.6567.26-888.58-179.01